Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas

被引:21
作者
Bertoni, F
Conconi, A
Luminari, S
Realini, C
Roggero, E
Baldini, L
Carobbio, S
Cavalli, F
Neri, A
Zucca, E
机构
[1] Ist Oncol Svizzera Italiana, Div Med Oncol, Bellinzona, Switzerland
[2] Univ Milan, Osped Maggiore IRCCS, Ist Sci Med, Serv Ematol, Milan, Italy
关键词
CD95; FAS; mutations; marginal zone B cell lymphoma; MALT;
D O I
10.1038/sj.leu.2401708
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Germline CD95 (also known as FAS, APT1 and APO1) gene mutations have been associated with benign lymphoproliferative diseases and autoimmune processes. Somatic mutations have been reported in human tumours, including lymphomas. Since marginal zone B cell lymphomas usually arise in a background of chronic inflammation, often of autoimmune origin, we searched for CD95 gene mutations in an unselected series of marginal zone B cell lymphomas. The CD95/FAS full coding region, comprising exon-intron junctions, was amplified from genomic DNA by polymerase chain reaction (PCR) in 10 separate reactions. PCR products were analysed by single-strand conformation polymorphism (SSCP) and visualised by silver staining. Bands exhibiting an altered electrophoretic mobility were sequenced. Twenty-seven cases of marginal zone B cell lymphomas of whom fresh or frozen tumour material was available (18 extranodal, five splenic and four nodal) were studied. Previously described silent polymorphisms in exons 7 (C836T) and 3 (T416C) were detected in 42% and in 19% of the cases, respectively. One silent T-to-A substitution at bp 431, within exon 3, was found in one case. Our results did not reveal the presence of CD95 somatic mutations in unselected cases of marginal zone B cell lymphomas. On the basis of our data, we cannot rule out that other genes coding for proteins involved in the CD95-induced apoptotic pathway might be altered. However, this pathway does not seem to play an important role in the pathogenesis of these lymphoma subtypes.
引用
收藏
页码:446 / 448
页数:3
相关论文
共 30 条
[1]   Death pathway genes Fas (Apo-1/CD95) and Bik (Nbk) show no mutations in colorectal carcinomas [J].
Abdel-Rahman, WM ;
Arends, MJ ;
Wyllie, AH ;
Morris, RG ;
Ramadan, ME .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :387-388
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia [J].
Beltinger, C ;
Böhler, T ;
Karawajew, L ;
Ludwig, WD ;
Schrappe, M ;
Debatin, KM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :722-728
[4]   GenBank [J].
Benson, DA ;
Boguski, MS ;
Lipman, DJ ;
Ostell, J ;
Ouellette, BFF ;
Rapp, BA ;
Wheeler, DL .
NUCLEIC ACIDS RESEARCH, 1999, 27 (01) :12-17
[5]  
Bertolo F, 1999, CLIN EXP RHEUMATOL, V17, P339
[6]   Clinical relevance of bcl-2(MBR)/J(H) rearrangement detected by polymerase chain reaction in the peripheral blood of patients with follicular lymphoma [J].
Bertoni, F ;
Bosshard, G ;
Roggero, E ;
Ceresa, E ;
Cavalli, F ;
Zucca, E .
BRITISH JOURNAL OF CANCER, 1997, 76 (01) :36-39
[7]   The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas [J].
Dierlamm, J ;
Baens, M ;
Wlodarska, I ;
Stefanova-Ouzounova, M ;
Hernandez, JM ;
Hossfeld, DK ;
De Wolf-Peeters, C ;
Hagemeijer, A ;
Van den Berghe, H ;
Marynen, P .
BLOOD, 1999, 93 (11) :3601-3609
[8]   DOMINANT INTERFERING FAS GENE-MUTATIONS IMPAIR APOPTOSIS IN A HUMAN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME [J].
FISHER, GH ;
ROSENBERG, FJ ;
STRAUS, SE ;
DALE, JK ;
MIDDELTON, LA ;
LIN, AY ;
STROBER, W ;
LENARDO, MJ ;
PUCK, JM .
CELL, 1995, 81 (06) :935-946
[9]  
FIUCCI G, 1994, IMMUNOGENETICS, V39, P437
[10]  
Gronbaek K, 1998, BLOOD, V92, P3018